Dissecting hypoxia‐dependent and hypoxia‐independent steps in the HIF‐1α activation cascade: implications for HIF‐1α gene therapy
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The heterodimeric hypoxia‐inducible factor (HIF)‐1 is a master transcriptional regulator of oxygen homeostasis and a possible target for gene therapy of ischemic disease. Although the role of oxygen concentration in HIF‐1α protein stabilization is well established, it is less clear whether and how oxygen‐regulated mechanisms contribute to HIF‐1α protein modifications, nuclear translocation, heterodimerization with the β‐subunit, recruitment of cofactors, and gene fraws‐activation. Because the HIF‐1α protein is proteolytically degraded under normoxic conditions, we established two HeLa Tet‐Off cell lines (HT42 and HT43), which inducibly overexpress high levels of HIF‐1α under normoxic conditions, allowing to distinguish hypoxia‐dependent from hypoxia‐independent activation mechanisms. Using these cells, we found that normoxically induced HIF‐1α is localized to the nucleus, binds DNA, and fraws‐activates reporter and endogenous target genes. The levels of p53 expression remained unaffected. The MAP kinase inhibitor PD98059 attenuated HIF‐1α protein modifications and fraws‐activation ability but not protein stabilization and DNA‐binding activity. Because overexpressed HIF‐1α is fully localized to the nucleus but displays only partial DNA‐binding and fraws‐activation activity, mitogen‐activated protein kinase‐dependent phosphorylation might be required for full HIF‐1 activation. HIF‐1α protein was also overexpressed in vivo, following the transplantation of HT42 cells into nude mice, demonstrating the feasibility of HIF‐1 α gene transfer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 2×
“The resulting plasmid was termed pBIHisHIFEGFP and was used for transfection into a HeLa-derived cell line, termed HeLa Tet-Off (Clontech) that expresses the chimeric tTa (33).”
MethodHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“Recently, it has been demonstrated that oxygenand iron-dependent prolyl-hydroxylase activity in cellular extracts hydroxylates proline 564, a highly conserved amino acid within the ODD domain of HIF-1α (11, 12).”
BackgroundHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 1×
“Increased p53 expression under conditions of severe hypoxia is associated with growth arrest and apoptosis (41, 42).”
BackgroundHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967 · cited 1×
“According to this model, p53 induces Mdm-2-mediated HIF-1α ubiquitinylation and proteasomal degradation (40).”
BackgroundLoss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840
An essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790
Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgård, R., Tora, L., Gassmann, M., & Poellinger, L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5221 · Cited by 470 · cited 2×
“The ARNT/HIF-1β (pCMVhARNT) expression vector (37) was kindly provided by L.”
MethodResultSelf-citation
Cited by
Hypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135
Self-citationIntegration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Self-citationHypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction
Yang, S., Kim, J., Ryu, J.-H., Oh, H., Chun, C.-H., Kim, B. J., Min, B. H., & Chun, J.-S. (2010) · Nature Medicine · doi:10.1038/nm.2153 · Cited by 527
Bruick, R. K. (2003) · Genes & Development · doi:10.1101/gad.1145503 · Cited by 440
Intracellular localisation of human HIF-1α hydroxylases:implications for oxygen sensing
Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J. H., Stolze, I., Klinger, M., Huang, W. Q., Wotzlaw, C., Hellwig-Bürgel, T., Jelkmann, W., et al. (2003) · Journal of Cell Science · doi:10.1242/jcs.00318 · Cited by 432
“It is still under discussion whether the translocation process is hypoxia inducible (Ruas et al., 2002) or not (Groulx and Lee, 2002; Hofer et al., 2001).”
BackgroundPaul, C., Teng, S., & Saunders, P. T. K. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.071779 · Cited by 355
Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels
Stiehl, D. P., Wirthner, R., Köditz, J., Spielmann, P., Camenisch, G., & Wenger, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601719200 · Cited by 289
Self-citationNegative and positive regulation of HIF-1: A complex network
Bárdos, J. I., & Ashcroft, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.05.001 · Cited by 285
Mylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., Kalousi, A., Georgatsou, E., Bonanou, S., & Simos, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605058200 · Cited by 266
HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes
Pfander, D., Cramer, T., Schipani, E., & Johnson, R. S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00385 · Cited by 258
Biology of bone marrow-derived endothelial cell precursors
Schatteman, G. C., Dunnwald, M., & Jiao, C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00662.2006 · Cited by 163
“As noted above, hypoxia is a potent mobilizer of BMD cells, and hypoxia-inducible factor-1 (HIF-1 ) activity is induced by hypoxia (77).”
Dang, D. T., Chen, F., Gardner, L. B., Cummins, J. M., Rago, C., Bunz, F., Kantsevoy, S. V., & Dang, L. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2887 · Cited by 122
Metadata
- Authors
- Hofer, T., Desbaillets, I., Höpfl, G., Gassmann, M., & Wenger, R. H.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-10-15
- Volume
- 15
- Issue
- 14
- Pages
- 1-23
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2166138837
- Cited by
- 84
- References
- 11
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.